Tag: Dyne Therapeutics Inc.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dyne Therapeutics

Dyne Therapeutics Inc’s recent filing unveils that its Chief Commercial Officer Friedl-Naderer Johanna unloaded Company’s shares for reported $1733.0 on

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Dyne Therapeutics Inc’s filing revealed that its Chief Commercial Officer Friedl-Naderer Johanna unloaded Company’s shares for reported $1733.0 on Mar